Advertisement

Topics

EIBER International GmbH Company Profile

18:02 EST 20th November 2017 | BioPortfolio

NIL

Contact

Phone: 49 6722 4951 0
Fax: 49 6722 4951 10
Email: info@eiber-international.de


News Articles [202 Associated News Articles listed on BioPortfolio]

Sandoz International GmbH Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 15102017] Prices from USD $350

Sandoz International GmbH Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Sandoz International GmbH Mergers Acquisitions MA, Partnerships Alliances and In...

Sandoz International GmbH Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 15062017] Prices from USD $350

Sandoz International GmbH Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Sandoz International GmbH Mergers Acquisitions MA, Partnerships Alliances and In...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Endocyte licenses radioligand prostate cancer therapy from ABX GMBH

Endocyte Inc. received exclusive global rights to the radioligand therapeutic PSMA617 (177LuPSMA617) from ABX GMBH.

DGAP-News: GBC Kapital GmbH: Erfolgreich abgeschlossene Kapitalmaßnahme der SYGNIS AG - beide Kapitalerhöhungen wurden von der GBC Kapital GmbH und der MC Services AG, jeweils als Co-Lead Manager Institutional Sales, begleitet und waren signifikant

GBC Kapital GmbH: Erfolgreich abgeschlossene Kapitalmaßnahme der SYGNIS AG - beide Kapitalerhöhungen wurden von der GBC Kapital GmbH und der MC Services AG, jeweils als Co-Lead Manager Institution.....

Körber Plans Takeover of Systec Services GmbH

     (Photo: http://mma.prnewswire.com/media/558312/SystecServices_Headquarters.jpg) With the planned takeover, Körber Medipak Systems GmbH, the holding company of Business Area Pharma Systems...

Cosmos Holdings Signs Letter of Intent To Acquire CC Pharma GmbH A Leading Re-importer of EU ...

CHICAGO, IL--(Marketwired - Jun 23, 2017) - Cosmos Holdings, Inc. (the Company) ( OTCQB : COSM), an international pharmaceutical company, announced today that Read more...

Original-Research: Valneva SE (von First Berlin Equity Research GmbH): BUY

Original-Research: Valneva SE - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Valneva SE Unternehmen: Valneva SE ISIN: FR0004056851 Anlass der Studie: U...

PubMed Articles [700 Associated PubMed Articles listed on BioPortfolio]

DIC in Decompensated Cirrhosis caused by Prothrombin Complex Concentrate and Recombinant Activated Factor VII: A Word of Caution.

We would like to respond to Scott et al. and the accompanying editorial.(1,2) Concentrated factor products like recombinant activated factor VII (NovoSeven(®) , Novo Nordisk Pharmaceuticals Inc.) an...

Torsional resistance of XP-endo Shaper at body temperature compared with several nickel-titanium rotary instruments.

To compare the torsional resistance of XP-endo Shaper (XPS; size 30, 0.01 taper, FKG Dentaire, La Chaux-de-Fonds, Switzerland) instruments at body temperature with TRUShape (TRS; size 30, 0.06 taper, ...

Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study.

To evaluate safety (primary objective) and efficacy of increasing doses (400 U up to 800 U) of incobotulinumtoxinA (Xeomin, Merz Pharmaceuticals GmbH) for patients with limb spasticity.

Biomechanical Characterization of Subclinical Keratoconus Without Topographic or Tomographic Abnormalities.

To present a case series of patients with subclinical keratoconus with normal topometric (anterior curvature) and tomographic findings in one eye who showed abnormalities detected by Corvis ST (Oculus...

Pulled-out locking screw re-screwed spontaneously in anterior cervical decompression and fusion with the zero-profile implant system: A case report.

The zero-profile, standalone device (Zero-P, Synthes GmbH, Switzerland) has been reported to be an effective and safe treatment method with similar clinical outcomes compared with plate. Instrumental ...

Clinical Trials [853 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

International AGD Database; Determinants of AGD and Establishment of Normative Data

Aim: To collate data on Anogenital Distance (AGD) from several population studies to build an international database for Anogenital Distance (AGD) Primary objective: To build a database p...

International Study on NoSocomial Pneumonia in Intensive CaRE

The International study on NoSocomial Pneumonia in Intensive CaRE (PneumoINSPIRE) is a prospective, international, multicentre, observational, cohort study. The study aims to provide up-to...

Effectiveness Study of the International Child Development Program

The objective of this study is to evaluate the effect of the International Child Development Program (ICDP). Research questions to be answered: 1. Does the ICDP affect children's psycho...

Companies [1756 Associated Companies listed on BioPortfolio]

EIBER International GmbH

NIL

Ormecon GmbH

Ormecon GmbH, with its location in Ammersbek/Germany, is the headquarter of Ormecon International. Ormecon GmbH was originally founded as "Ormecon Chemie GmbH & Co. KG" in 1996, as a 100% subsidiary o...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

BEBIG Isotopen- und Medizintechnik GmbH

since March 2004 MCP Medical International is a part of BEBIG Isotopen- und Medizintechnik GmbH, Berlin. BEBIG is an international developer and producer of radioactive sources and devices for medical...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

More Information about "EIBER International GmbH" on BioPortfolio

We have published hundreds of EIBER International GmbH news stories on BioPortfolio along with dozens of EIBER International GmbH Clinical Trials and PubMed Articles about EIBER International GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of EIBER International GmbH Companies in our database. You can also find out about relevant EIBER International GmbH Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record